Consumption of Nuts in the Prevention of Cardiovascular Disease

Current Nutrition Reports

Volumn 2, Issue 4, 2013, Pages 258-266

  Sabaté, Joan ^a   Wien, Michelle ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Antioxidants; Cardiovascular; Cholesterol; Endothelial function; Fatty acids; Hypertension; Inflammation; Lipids; Mortality; Nuts; Phytochemicals

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRACE ELEMENT; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIETARY FIBER; DISEASE ASSOCIATION; DNA DAMAGE; FOOD INTAKE; GLYCEMIC INDEX; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; INFLAMMATION; LIPID ANALYSIS; LIPID OXIDATION; MACRONUTRIENT; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); NUT; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84900328828     PISSN: None     EISSN: 21613311     Source Type: Journal    
DOI: 10.1007/s13668-013-0059-x     Document Type: Review

References (65)

1. World Health Organization. Death and disability due to CVDs (heart attacks and strokes). In Global Atlas on cardiovascular disease prevention and control. In: Mendis S, Puska P, Norrving editors. Geneva: WHO Press; 2011: 8-13. This book chapter presents current global statistics for death and disability due to cardiovascular diseases.
2. Kris-Etherton PM, Yu-Poth S, Sabate J, et al. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 1999;70: 504S-11S.
3. Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors. 2009;35: 266-72.
4. Kaminski WE, Jendraschak E, Kiefl R, et al. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood. 1993;81: 1871-9.
5. Brufau G, Boatella J, Rafecas M. Nuts: source of energy and macronutrients. Br J Nutr. 2006;96 Suppl 2: S24-8.
6. Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol. 2006;33: 1-8.
7. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333: 276-82.
8. Jenkins DJ, Wolever TM, Spiller G, Buckley G, Lam Y, Jenkins AL, et al. Hypocholesterolemic effect of vegetable protein in a hypocaloric diet. Atherosclerosis. 1989;78: 99-107.
9. Salas-Salvado J, Bullo M, Perez-Heras A, Ros E. Dietary fibre, nuts and cardiovascular diseases. Br J Nutr. 2006;96 Suppl 2: S46-51.
10. Blomhoff R, Carlsen MH, Andersen LF, et al. Health benefits of nuts: potential role of antioxidants. Br J Nutr. 2006;96 Suppl 2: S52-60.
11. Ostlund Jr RE. Phytosterols in human nutrition. Annu Rev Nutr. 2002;22: 533-49.
12. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med. 1997;336: 1117-24.
13. Fraser GE. Nut consumption, lipids, and risk of a coronary event. Clin Cardiol. 1999;22: 11-5.
14. Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract. 2008;23: 142-51.
15. Houtman JP. Trace elements and cardiovascular diseases. J Cardiovasc Risk. 1996;3: 18-25.
16. Sabaté J, Fraser GE, Burke K, et al. Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med. 1993;328: 603-7.
17. U. S. Food and Drug Administration: Qualified health claims: Letter of enforcement discretion-nuts and coronary heart disease (DocketNo. 02P-0505). Available at http://www. fda. gov/Food/LabelingNutrition/LabelClaims/QualifiedHealthClaims/ucm072926. htm. Accessed August 2013.
18. •• Sabaté J, Oda K, Ros E: Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 2010, 170: 821-827. This article presents important pooled analysis data from 25 nut intervention trials conducted in seven countries showing that nut consumption lowers cornonary heart disease risk.
19. Banel DK, Hu FB. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr. 2009;90: 56-63.
20. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111: 1999-2012.
21. •• Maranhao PA, Kraemer-Aguiar LG, de Oliveira CL, et al.: Brazil nuts intake improves lipid profile, oxidative stress and microvascular function in obese adolescents: a randomized controlled trial. Nutr Metab 2011, 8: 32. This article presents some of the first data to document the beneficial effects of Brazil nut consumption among obese adolescents.
22. Coates AM, Howe PR. Edible nuts and metabolic health. Curr Opin Lipidol. 2007;18: 25-30.
23. Lopez-Uriarte P, Bullo M, Casas-Agustench P, et al. Nuts and oxidation: a systematic review. Nutr Rev. 2009;67: 497-508.
24. Nash SD, Nash DT. Nuts as part of a healthy cardiovascular diet. Curr Atheroscler Rep. 2008;10: 529-35.
25. Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr. 2009;89: 1649S-56S.
26. Reaven PD, Witztum JL. Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Annu Rev Nutr. 1996;16: 51-71.
27. Berry SE, Tydeman EA, Lewis HB, et al. Manipulation of lipid bioaccessibility of almond seeds influences postprandial lipemia in healthy human subjects. Am J Clin Nutr. 2008;88: 922-9.
28. Cortes B, Nunez I, Cofan M, et al. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. J Am Coll Cardiol. 2006;48: 1666-71.
29. Jenkins DJ, Kendall CW, Josse AR, et al. Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr. 2006;136: 2987-92.
30. Torabian S, Haddad E, Rajaram S, et al. Acute effect of nut consumption on plasma total polyphenols, antioxidant capacity and lipid peroxidation. J Hum Nutr Diet. 2009;22: 64-71.
31. • Hudthagosol C, Haddad EH, McCarthy K, et al.: Pecans acutely increase plasma postprandial antioxidant capacity and catechins and decrease LDL oxidation in humans. J Nutr 2011, 141: 56-62. This article features interesting data showing that bioactive constituents of pecans are absorbable and contribute to postprandial antioxident defenses.
32. • Kay CD, Gebauer SK, West SG, et al.: Pistachios increase serum antioxidants and lower serum oxidized-LDL in hypercholesterolemic adults. J Nutr 2010, 140: 1093-1098. This article presents data showing that consumption of a pistachio-enriched healthy diet confers cardioprotective benefits beyond lipid-lowering, i. e., decreased oxidized-LDL.
33. Fito M, Guxens M, Corella D, et al. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med. 2007;167: 1195-203.
34. • Lopez-Uriarte P, Nogues R, Saez G, et al.: Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin Nutr 2010, 29: 373-380. This article presents some of the first data showing that despite the possible adverse pro-oxidant effect of consuming PUFA-rich nuts, no deleterious effect on biomarkers of oxidative stress or endothelial function in patients with metabolic syndrome was observed.
35. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145: 1-11.
36. Ros E, Nunez I, Perez-Heras A, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation. 2004;109: 1609-14.
37. • Rajaram S, Connell KM, Sabaté J: Effect of almond-enriched high-monounsaturated fat diet on selected markers of inflammation: a randomised, controlled, crossover study. Br J Nutr 2010, 103: 907-912. This article provides data on the effects of almond consumption on markers of inflammation, showing reductions in E-selectin and C-reactive protein in the context of null results for IL-6 and fibrinogen.
38. Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM, et al. Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis. 2009;204: e70-6.
39. Mena MP, Sacanella E, Vazquez-Agell M, et al. Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr. 2009;89: 248-56.
40. Kay CD, Kris-Etherton PM, West SG. Effects of antioxidant-rich foods on vascular reactivity: review of the clinical evidence. Curr Atheroscler Rep. 2006;8: 510-22.
41. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81: 292S-7S.
42. Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr. 2004;134: 2880S-7S. discussion 2895S.
43. de Koning EJ, Rabelink TJ. Endothelial function in the post-prandial state. Atheroscler. 2002;3: S11-6.
44. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr. 2001;73: 673-86.
45. Sanderson P, Sattar N, Olthof M, et al. Dietary lipids and vascular function: UK Food Standards Agency workshop report. Br J Nutr. 2004;91: 491-500.
46. West SG. Effect of diet on vascular reactivity: an emerging marker for vascular risk. Curr Atheroscler Rep. 2001;3: 446-55.
47. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115: 1285-95.
48. •• Ma Y, Njike VY, Millet J, et al.: Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care 2010, 33: 227-232. This report was the first to demonstrate that a walnut-enriched ad libitum diet improves endothelial function in individuals with type 2 diabetes, which suggests that a simple dietary nut intervention may confer a reduction in overall cardiovascular risk.
49. Official Journal of the European Union. Available at http://eur-lex. europa. eu/LexUriServ/LexUriServ. do?uri=OJ: L: 2012: 136: FULL: EN: PDF. Accessed August 2013. This journal contains a notice for a specific health claim for walnuts in the European Union that states "Walnuts contribute to the improvement of the elasticity of the blood vessels," and may be used only for food that provides a daily intake of 30 grams of walnuts.
50. Villegas R, Gao YT, Yang G, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008;87: 162-7.
51. • Kochar J, Gaziano JM, Djousse L: Nut consumption and risk of type II diabetes in the Physicians' Health Study. Eur J Clin Nutr 2010, 64: 75-79. This report shows data that does not support an association between nut consumption and incident type 2 diabetes among a prospective cohort of 20, 224 male participants enrolled in the Physicians' Health Study.
52. Barcelo F, Perona JS, Prades J, et al. Mediterranean-style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients: the Prevencion con Dieta Mediterranea Study. Hypertension. 2009;54: 1143-50.
53. Fuster V, Ryden LE, Cannom DS, ACC/AHA/ESC, et al. Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;2006(114): e257-354.
54. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285: 2370-5.
55. • Khawaja O, Gaziano JM, Djousse L: Nut consumption and risk of atrial fibrillation in the Physicians' Health Study. Nutr J 2012, 11: 17. This report shows data that does not support an association between nut consumption and incident atrial fibrillation among a prospective cohort of 21, 054 male participants enrolled in the Physicians' Health Study.
56. Fraser GE, Sabaté J, Beeson WL, et al. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study Arch Intern Med. 1992;152: 1416-24.
57. Hu FB, Stampfer MJ, Manson JE, et al. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ. 1998;317: 1341-5.
58. Albert CM, Gaziano JM, Willett WC, et al. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002;162: 1382-7.
59. Ellsworth JL, Kushi LH, Folsom AR. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. Nutr Metab Cardiovasc Dis. 2001;11: 372-7.
60. Kelly Jr JH, Sabaté J. Nuts and coronary heart disease: an epidemiological perspective. Br J Nutr. 2006;96 Suppl 2: S61-7.
61. Kris-Etherton PM, Hu FB, Ros E, et al. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138: 1746S-51S.
62. •• Guasch-Ferre M, Bullo M, Martinez-Gonzalez MA, et al.: Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial. BMC Med 2013, 11: 164. This article presents findings from 7, 216 participants enrolled in the PREDIMED trial that showed that participants that consumed >3 weekly servings of total nuts, walnuts or other nuts (excluding walnuts) at baseline had significant reductions in cardiovascular mortality of 55, 47 and 58 %, respectively.
63. •• Estruch R, Ros E, Salas-Salvado J, et al.: Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368: 1279-1290. This article presents findings from 7, 447 participants enrolled in the PREDIMED trial that demonstrated that a Mediterranean diet supplemented with mixed nuts daily lowers the risk of CVD by 30 %.
64. de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99: 779-85.
65. Brown L, Rosber B, Willet W, et al. Nut consumption and risk of recurrent coronary heart disease. FASEB J. 1999;13: A538.